Teprotumumab for Thyroid Eye Disease-related Strabismus.
Liane O DallalzadehGeorge A VillatoroLillian ChenMyung S SimMansoor MovagharShira L RobbinsJustin N KarlinMonica R KhitriFederico G VelezBobby S KornJoseph L DemerDaniel B RootmanDavid B GranetDon O KikkawaPublished in: Ophthalmic plastic and reconstructive surgery (2024)
Teprotumumab produced a statistically significant reduction in vertical but not horizontal strabismus angles in primary position at distance. Extraocular motility in all 4 ductions also improved. A substantial minority of patients still required strabismus surgery following teprotumumab.